University of Crete (UOC)
Επίδραση των αυξητικών παραγόντων στη σύνθεση των πρωτεογλυκανών - γλυκοζαμινογλυκανών σε κυτταρικές σειρές καρκίνου του παχέος εντέρου
Abstract
dc:descriptionColon cancer is one of the leading causes of cancer-associated death among men and women worldwide. It has been shown that genomic instability, as well as environmental factors can be correlated to the risk of colon cancer however, the pathogenesis of the malignancy still remains unknown. Many colorectal cancers are thought to arise from adenomatous polyps in the colon. The complex interactions among the cancer cells, their extracellular matrix (ECM) and the surrounding normal cells are thought to play a pivotal role in tumor development and progression. The composition of the ECM affects various cellular functions, such as proliferation, adhesion, migration and differentiation. Proteoglycans (PGs), major constituents of the ECM, through their core proteins or via their glycosaminoglycan (GAG) chains are able to interact with collagens, growth factors, growth factor receptors and adhesion molecules and through these interactions may participate in the regulation of many cellular events. The molecular characteristics of colon cancer cells and their stroma, as well as their association with the development and the progression of the malignancy have not been adequately studied. The structural analysis and the role of GAGs/PGs that are produced by colon cancer cells and the surrounding cells may contribute to the better understanding of these glycocomplexes, which participate in the regulation of numerous cellular events, as well as in the cell malignant transformation. The understanding of the interactions among cancer cells and their microenvironment may contribute to colon cancer treatment. In this study, the synthesis and the distribution of GAGs among the cell membrane and the culture medium by two human colon cancer cells, HT29 and SW1116 were examined. The results demonstrated that both estrogen receptorpositive (ER+) cancer cell lines produced hyaluronan (HA), both extracellular and membrane-associated galactosaminoglycans (GalAGs) and heparan sulfate (HS), with the HT29 cells producing all GAG fractions at significantly higher rates. Abstract VIII The effects of genistein on the synthesis of these secreted or cell-associated macromolecules, as well as on the growth of HT29 and SW1116 cell lines were also studied. It is well known that the soy isoflavone genistein can affect cell metabolism by specifically inhibiting protein tyrosine kinase (PTK) and/or interacting with the estrogen receptors (ERs). The observed dose-dependent inhibitory effect of genistein on the synthesis of both secreted and cell-associated GAG/PG by the SW1116 cells, as well as on their growth, was suggestive of a PTK mechanism. On the other hand, the synthesis of GAGs/PGs by HT29 cells in the presence of genistein was dependent on their type and localization which implies the active participation of the ERs, which was further supported by the observed growth stimulation at low concentrations of genistein. Quantitative and qualitative changes in GAGs/PGs production, and consequently in the ECM composition, have been suggested to have a role in the development of some types of cancer. Therefore, the effects of endogenous and exogenously added GAGs on the proliferation of HT29, SW1116 and HCT116 human colon cancer cell lines were examined. For this purpose exogenously added GAGs (chondroitin sulfate-CS, dermatan sulfate-DS, hyaluronan-HA and heparin), an inhibitor of endogenous GAG sulfation and specific glycosidases to cleave cellassociated glycosaminoglycans were utilized. The obtained results showed that colon cancer cell growth was exclusively stimulated by exogenously added heparin and insensitive to endogenous GAGs/PGs production, in a sulfation pattern-related manner. Numerous mechanisms of heparins’ action have been postulated including the regulation of growth factors / growth factor receptors, mitogen activated protein kinases (MAPKs) activities or the modulation of cell cycle progression. Specifically, HSPGs/heparin have been demonstrated to increase the affinity of FGF-2 to its respective, FGFR1-4, receptors. The active role of FGF-pathways has been suggested in the early stages of colorectal tumorigenesis. Moreover, it has been shown that HS chains stimulate the proliferation of colon cancer cells via a mechanism involving increased expression of tyrosine kinase receptors of EGF. Aim of this study was to examine the possible involvement of the FGF-2 and EGF signaling on the heparininduced effect on HT29, SW1116 and HCT116 colon cancer cell lines. .......................................................................................................................................
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzinikolaou, Georgia
- Χατζηνικολάου, Γεωργία
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/20397